Market Tracker

03/23 5:16pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

3.91
Delayed Data
As of 3:59pm ET
 +0.02 / +0.51%
Today’s Change
3.49
Today|||52-Week Range
10.98
-9.28%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close3.89
Today’s open3.88
Day’s range3.80 - 3.95
Volume92,971
Average volume (3 months)271,549
Market cap$191.5M
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+58.79%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc+0.10+2.27%
AVXLAnavex Life Sciences...+0.25+4.36%
ARWRArrowhead Pharmaceut...+0.05+2.78%
BCLIBrainstorm Cell Ther...+0.07+1.80%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts